epigallocatechin gallate has been researched along with Glaucoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YL; Chu, WK; Lin, HL; Niu, YY; Pang, CP; Qin, YJ; Zhang, HY; Zhang, YL; Zhang, YQ | 1 |
| Chen, L; Jiang, L; Lai, TY; Shen, C | 1 |
| Osborne, NN | 1 |
3 other study(ies) available for epigallocatechin gallate and Glaucoma
| Article | Year |
|---|---|
Epigallocatechin-3-gallate (EGCG) inhibits myofibroblast transformation of human Tenon's fibroblasts.
Topics: Catechin; Cell Movement; Cell Proliferation; Cells, Cultured; Fibroblasts; Glaucoma; Humans; Myofibroblasts; Neuroprotective Agents; Protease Inhibitors; Signal Transduction; Tenon Capsule | 2020 |
Neuroprotective effect of epigallocatechin-3-gallate in a mouse model of chronic glaucoma.
Topics: Administration, Oral; Animals; Catechin; Cell Survival; Chronic Disease; Female; Glaucoma; Intraocular Pressure; Mice, Inbred C57BL; Neuroprotective Agents; Retinal Ganglion Cells | 2015 |
Pathogenesis of ganglion "cell death" in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria.
Topics: Antioxidants; Axons; Catechin; Cell Death; Creatine; Glaucoma; Humans; Mitochondria; Neuroprotective Agents; Niacinamide; Optic Disk; Retinal Ganglion Cells; Thioctic Acid; Vitamin B Complex | 2008 |